基于FAERS数据库的瓦拉西克洛维尔或阿西克洛维尔严重皮肤不良事件的信号挖掘研究
KaiLi Mao1, Jiang Li2, XinLiang Zhu3
1Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
Expert review of clinical pharmacology
|December 9, 2023
概括
瓦拉西克洛维尔和阿西克洛维尔显示严重皮肤不良反应 (SCARs) 的风险增加,包括DRESS,AGEP,TEN和SJS. 这一分析提供了对这些抗病毒药物的更安全的临床使用的见解.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 严重的皮肤不良反应 (SCAR) 是药物诱导的严重事件.
- 瓦拉西克洛维尔和阿西克洛维尔是常见的抗病毒药物.
- 了解这些药物的SCARs概况对于患者安全至关重要.
研究的目的:
- 对与瓦拉西克洛维尔和阿西克洛维尔相关的SCAR进行全面的实证调查.
- 通过FDA的FAERS数据库来评估SCARs的风险信号.
- 为这些抗病毒药物的合理临床应用提供理论基础.
主要方法:
- 从2004年第一季度到2023年第二季度的FDA不良事件报告系统 (FAERS) 数据库的数据挖掘.
- 利用比例分析和贝叶斯方法来检测SCARs信号.
- 分析了临床特征,发病时间,并进行了相关性和分层分析.
主要成果:
- 瓦拉西克洛维尔和阿西克洛维尔都显示了SCARs的积极信号,包括DRESS,AGEP,TEN,SJS-TEN重叠和SJS.
- SCARs的中位发病时间各不相同,DRESS在valaciclovir出现大约30天,而在acyclovir出现大约10天.
- 确定了瓦拉西克洛维尔,阿西克洛维尔和SCARs之间的关联,独立于组合药物效应.
结论:
- 该研究确定了与瓦拉西克洛维尔和阿西克洛维尔相关的SCARs风险趋势.
- 对FAERS数据库的分析为在临床实践中识别SCAR提供了有价值的见解.
- 这些发现支持关于使用这些抗病毒药物的知情决策.
更多相关视频
相关概念视频
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


